Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Neurofibromatosis 1

fluorodeoxyglucose f18 has been researched along with Neurofibromatosis 1 in 55 studies

Research

Studies (55)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.64)	18.2507
2000's	20 (36.36)	29.6817
2010's	31 (56.36)	24.3611
2020's	2 (3.64)	2.80

Authors

Authors	Studies
Anten, MHME; Broen, MPG; Geitenbeek, RTJ; Graven, LH; Martin, E; Taal, W; van der Pol, JAJ; Verhoef, C	1
Ikuta, K; Imagama, S; Ito, K; Ito, S; Koike, H; Nishida, Y; Sakai, T; Urakawa, H	1
Cook, GJR; Ferner, R; Goh, V; Lovat, E; Siddique, M; Warbey, VS	1
Amann, G; Aszmann, O; Azizi, AA; Benkoe, TM; Hacker, M; Happak, W; Hojreh, A; Kasprian, G; Peyrl, A; Rausch, I; Slavc, I; Staudenherz, A; Theisen, BE; Traub-Weidinger, T; Wadsak, W; Weber, M	1
Fu, Z; Ren, J; Yang, G; Zhou, J	1
Anten, M; Boone, K; Brinkman, M; Jentjens, S; Nelemans, PJ; Stumpel, CTRM; van Kroonenburgh, MJPG	1
Brammer, M; de Paula, JJ; de Souza Costa, D; Malamut, C; Malloy-Diniz, LF; Mamede, M; Miranda, DM; Romano-Silva, MA; Schütze, M	1
Ahlawat, S; Belzberg, A; Blakeley, J; Fayad, LM; Montgomery, E; Subramaniam, RM	1
Adam, G; Apostolova, I; Bannas, P; Derlin, T; Friedrich, RE; Herrmann, J; Mautner, VF; Salamon, J; Veldhoen, S; Yamamura, J	1
Bredella, MA; Harris, GJ; Kassarjian, A; Lim, R; Merker, VL; Muzikansky, A; Plotkin, SR; Urban, T	1
Derlin, T; Hagel, C; Mautner, VF	1
Blay, JY; Combemale, P; Giammarile, F; Goulart, DM; Guillot, B; Mognetti, T; Pinson, S; Valeyrie-Allanore, L; Wolkenstein, P	1
Deroose, CM; Gheysens, O; Lips, N; Moerman, P; Peetermans, WE; Schöffski, P; Slabbaert, K; Vancleynenbreugel, B	1
Akiyama, M; Ichimura, K; Iwatsuki, K; Shiomi, M; Yamaguchi, M; Yamasaki, O	1
Blakeley, JO; Chaudhry, M; Chirindel, A; Wahl, R	1
D'souza, MM; D'souza, P; Jaimini, A; Mondal, A; Pandey, S; Sharma, R; Sondhi, P; Tripathi, RP	1
Derlin, T; Friedrich, RE; Hagel, C; Mautner, VF; Salamon, J	1
Adam, G; Derlin, T; Mautner, VF; Salamon, J	1
Amthauer, H; Apostolova, I; Brenner, W; Buchert, R; Derlin, T; Granström, S; Mautner, VF; Salamon, J	1
Blay, JY; Brahmi, M; Combemale, P; Decouvelaere, AV; Mognetti, T; Pinson, S; Ranchere, D; Renard, C; Thiesse, P	1
Adam, G; Apostolova, I; Derlin, T; Laqmani, A; Mautner, VF; Papp, L; Salamon, J; Tóth, Z	1
Brugières, P; Djelbani-Ahmed, S; Itti, E; Luciani, A; Ortonne, N; Rahmouni, A; Sbidian, E; Valeyrie-Allanore, L; Van Der Gucht, A; Wolkenstein, P; Zehou, O	1
Nguyen, BD; Sugrue, G	1
Dry, SM; Eilber, FC; James, AW; Shurell, E; Singh, A	1
Choe, YH; Chung, MJ; Jin, GY; Kim, HJ; Kim, SR; Lee, HB; Lee, YC; Park, SJ	1
Cane, P; Dartnell, J; Ferner, R; Lang-Lazdunski, L; Pilling, J	1
Calonje, E; Dunn, JT; Ferner, RE; O'Doherty, MJ; Warbey, VS	1
Alavi, A; Bertagna, F; Biasiotto, G; Bosio, G; Giubbini, R; Rodella, C; Rosenbaum, J; Savelli, G	1
Guha, A; Hendler, A; Karabatsou, K; Kiehl, TR; Wilson, DM	1
Howman-Giles, R; London, K; Moharir, M; North, K	1
Bercich, L; Bertagna, F; Biasiotto, G; Bosio, G; Fisogni, S; Giubbini, R	1
Amrami, KK; Esther, RJ; Lowe, VJ; Shahid, KR; Spinner, RJ	1
Drubach, L; Fahey, F; Irons, M; Tsai, LL; Ullrich, NJ; Voss, S	1
Iwasaki, T; Kawahara, K; Ohta, M; Okimura, A	1
Baldwin, A; Derdak, J; Dombi, E; Gillespie, A; Kurwa, A; Meany, H; Reynolds, J; Salzer, W; Tsokos, M; Whatley, M; Widemann, B	1
Derlin, T; Friedrich, RE; Gawad, K; Hagel, C; Zustin, J	1
Adam, G; Bannas, P; Bockhorn, M; Busch, JD; Derlin, T; Friedrich, RE; Hagel, C; Herrmann, J; Mautner, VF; Salamon, J	1
Apostolova, I; Derlin, T; Friedrich, RE; Hagel, C; Mautner, VF; Münster, S; Tornquist, K; Wedegärtner, U	1
Attigah, N; Cardona, S; Dimitrakopoulou-Strauss, A; Hinz, U; Lehnert, T; Mechtersheimer section sign, G; Schwarzbach, M	1
Carreras-Delgado, JL; Hornedo-Muguiro, J; Lapeña-Gutiérrez, L; Montz-Andrée, R; Pérez-Castejón, MJ; Ruíz-Hernández, G; Salinas-Hernández, P	1
Bloom, DA; Chander, S; Getzen, TM; Joyrich, RN; Littrup, PJ; Taub, JW; Westphal, SM; Zak, IT; Zingas, AP	1
Brenner, W; Buchert, R; Clausen, M; de Wit, M; Friedrich, RE; Gawad, KA; Hagel, C; Mautner, VF; von Deimling, A	1
Ahlman, H; Bümming, P; Nilsson, B; Nilsson, O; Sörensen, J	1
Basu, S; Nair, N	1
Pomper, MG; Solomon, SB	1
Berdel, WE; Bremer, C; Brunnberg, U; Mesters, RM; Müller-Tidow, C; Schleicher, C; Schliemann, C; Schmidt, E; Staebler, A; Stegger, L; Thoennissen, NH	1
Bredella, MA; Fischman, AJ; Hornicek, F; Ouellette, HA; Plamer, WE; Plotkin, SR; Torriani, M; Williams, Z	1
Ahn, MI; Cho, KD; Park, YH; Son, JM; Yoo, J	1
Calonje, E; Ferner, RE; Golding, JF; Jan, W; O'Doherty, M; Sanjayanathan, V; Smith, M	1
Bensaid, B; Combemale, P; Drouet, A; Galoisy-Guibal, L; Giammarile, F; Mognetti, T; Pinson, S	1
Brenner, W; Buchert, R; Clausen, M; Friedrich, RE; Gronowsky, M; Mautner, VF; Mester, J; von Borczyskowski, D; Wilke, F	1
Balestri, P; Calistri, L; Di Bartolo, RM; Fazio, F; Fois, A; Grana, C; Lucignani, G; Magliani, L; Perani, D	1
Bonstelle, CT; Chen, K; Kaplan, AM; Lawson, MA; Reiman, EM; Wodrich, DL	1
Bingham, J; Cronin, BF; Ferner, RE; Hughes, RA; Lucas, JD; O'Doherty, MJ; Smith, MA	1
Ferner, RE; Gutmann, DH	1

Reviews

5 review(s) available for fluorodeoxyglucose f18 and Neurofibromatosis 1

Article	Year
The value of 18F-FDG PET/CT in patient with neurofibromatosis type 1: A case report and literature review. Medicine, 2018, Volume: 97, Issue:20 Topics: Adolescent; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography	2018
Evaluation of the most commonly used (semi-)quantitative parameters of 18F-FDG PET/CT to detect malignant transformation of neurofibromas in neurofibromatosis type 1. Nuclear medicine communications, 2018, Volume: 39, Issue:11 Topics: Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography	2018
Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2015, Volume: 187, Issue:12 Topics: Adult; Cell Transformation, Neoplastic; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult	2015
Malignant Peripheral Nerve Sheath Tumor. Surgical oncology clinics of North America, 2016, Volume: 25, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma	2016
Intrapulmonary neurofibroma independent of neurofibromatosis type 1. General thoracic and cardiovascular surgery, 2012, Volume: 60, Issue:3 Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neurofibroma; Neurofibromatosis 1; Pneumonectomy; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Treatment Outcome	2012

Trials

3 trial(s) available for fluorodeoxyglucose f18 and Neurofibromatosis 1

Article	Year
Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [ Pediatric blood & cancer, 2018, Volume: 65, Issue:1 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography	2018
Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:4 Topics: Adolescent; Adult; Comorbidity; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate	2006
Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1. Nuclear medicine communications, 2008, Volume: 29, Issue:1 Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 1; Radionuclide Imaging; Radiopharmaceuticals; Thalamus	2008

Other Studies

47 other study(ies) available for fluorodeoxyglucose f18 and Neurofibromatosis 1

Article	Year
Diagnostic value of Journal of neuro-oncology, 2022, Volume: 156, Issue:3 Topics: Adult; Child; Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity	2022
Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study. Cancer science, 2021, Volume: 112, Issue:3 Topics: Adolescent; Adult; Aged; Carcinogenesis; Child; Cross-Sectional Studies; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; ROC Curve; Young Adult	2021
Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:11 Topics: Adolescent; Adult; Aged; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Limit of Detection; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1. PloS one, 2018, Volume: 13, Issue:9 Topics: Adolescent; Adult; Brain; Child; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Neurofibromatosis 1; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Principal Component Analysis; Young Adult	2018
Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging. Skeletal radiology, 2013, Volume: 42, Issue:9 Topics: Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Multiple Primary; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms	2013
18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off. European radiology, 2014, Volume: 24, Issue:2 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Male; Middle Aged; Muscle, Skeletal; Neoplasm Staging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Young Adult	2014
Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion. Clinical nuclear medicine, 2014, Volume: 39, Issue:5 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Whole Body Imaging; Young Adult	2014
[Syndromic abdominal ganglioneuroma: a rare cause of false-positive findings in the F-18 FDG PET / CT in neurofibromatosis type 1]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2014, Volume: 186, Issue:7 Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Ganglioneuroma; Humans; Intestinal Neoplasms; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1. PloS one, 2014, Volume: 9, Issue:2 Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Child, Preschool; Demography; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma	2014
The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I. BMC medical imaging, 2014, May-29, Volume: 14 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed	2014
Hybrid neurofibroma/schwannoma in neurofibromatosis type I exhibiting high FDG uptake in PET imaging. European journal of dermatology : EJD, 2015, Volume: 25, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms	2015
18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3 Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Young Adult	2015
(18)F-FDG PET/CT in an unusual case of cardiac plexiform neurofibromatosis. Clinical nuclear medicine, 2015, Volume: 40, Issue:6 Topics: Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Multimodal Imaging; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Foreign Body Abscess Mimicking a Malignant Peripheral Nerve Sheath Tumor in a Patient With Neurofibromatosis Type 1. Clinical nuclear medicine, 2015, Volume: 40, Issue:8 Topics: Abscess; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Male; Medical Errors; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nerves; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Cerebral glucose metabolism in adults with neurofibromatosis type 1. Brain research, 2015, Nov-02, Volume: 1625 Topics: Adult; Brain Mapping; Case-Control Studies; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Thalamus; Tomography Scanners, X-Ray Computed; Young Adult	2015
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients. PloS one, 2015, Volume: 10, Issue:10 Topics: Adolescent; Adult; Biopsy; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2015
Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT. PloS one, 2015, Volume: 10, Issue:12 Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2015
Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1. PloS one, 2016, Volume: 11, Issue:3 Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 1; Prognosis; Radionuclide Imaging; Retrospective Studies; Sarcoma; Survival Rate; Tumor Burden; Young Adult	2016
Gastrointestinal stromal tumour in neurofibromatosis 1: 18F FDG PET/CT imaging. BMJ case reports, 2016, Aug-16, Volume: 2016 Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Jejunal Neoplasms; Middle Aged; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Solitary neurofibroma of intercostal region in a patient without neurofibromatosis type 1. The American journal of the medical sciences, 2008, Volume: 336, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibroma; Neurofibromatosis 1; Positron-Emission Tomography; Thoracic Wall; Tomography, X-Ray Computed	2008
Malignant triton tumor of the brachial plexus invading the left thoracic inlet: a rare differential diagnosis of pancoast tumor. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:1 Topics: Adult; Brachial Plexus; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neurilemmoma; Neurofibromatosis 1; Pancoast Syndrome; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, X-Ray Computed	2009
[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2009
Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Japanese journal of radiology, 2009, Volume: 27, Issue:8 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nerves; Positron-Emission Tomography; Radiopharmaceuticals; Thigh; Tomography, X-Ray Computed	2009
Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1. Neurosurgery, 2009, Volume: 65, Issue:4 Suppl Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Peripheral Nerves; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Tomography, X-Ray Computed; Young Adult	2009
Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:7 Topics: Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Neurofibromatosis 1; Optic Nerve Glioma; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2010
Malignant transformation to schwannoma in a patient affected by type 1 neurofibromatosis as demonstrated by F-18-FDG-PET/CT. Nuclear medicine review. Central & Eastern Europe, 2010, Volume: 13, Issue:1 Topics: Aged; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Male; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1. Journal of surgical orthopaedic advances, 2011,Summer, Volume: 20, Issue:2 Topics: Adult; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals	2011
[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. Journal of neuro-oncology, 2012, Volume: 108, Issue:3 Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Child, Preschool; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult	2012
18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST). Pediatric blood & cancer, 2013, Volume: 60, Issue:1 Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals	2013
Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up. Anticancer research, 2012, Volume: 32, Issue:10 Topics: Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Membrane Glycoproteins; Mucin-1; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; S100 Proteins; Young Adult	2012
Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:5 Topics: Adolescent; Adult; Aged; Biological Transport; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Young Adult	2013
Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Clinical nuclear medicine, 2013, Volume: 38, Issue:1 Topics: Adolescent; Adult; Child; Child, Preschool; Comparative Effectiveness Research; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed; Young Adult	2013
Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2003, Volume: 29, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
[Positron emission tomography in a patient with Von Recklinghausen disease and left dorsal neurofibrosarcoma]. Revista espanola de medicina nuclear, 2003, Volume: 22, Issue:6 Topics: Adult; Back; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Neurofibrosarcoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Spinal Cord Compression; Tomography, Emission-Computed	2003
Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET. Clinical nuclear medicine, 2004, Volume: 29, Issue:7 Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Retroperitoneal Neoplasms; S100 Proteins; Tomography, Emission-Computed	2004
Use of 2-tracer PET to diagnose gastrointestinal stromal tumour and pheochromocytoma in patients with Carney triad and neurofibromatosis type 1. Scandinavian journal of gastroenterology, 2006, Volume: 41, Issue:5 Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Leiomyoma; Male; Mediastinal Neoplasms; Middle Aged; Neurofibromatosis 1; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals	2006
Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: a case study and review of the literature. Journal of neuro-oncology, 2006, Volume: 80, Issue:1 Topics: Adult; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma	2006
Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease. Journal of neuro-oncology, 2007, Volume: 82, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma	2007
Chemotherapy in metastatic malignant triton tumor: report on two cases. Oncology reports, 2007, Volume: 18, Issue:4 Topics: Adult; Antineoplastic Agents; Cecal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Neoadjuvant Therapy; Neurilemmoma; Neurofibromatosis 1; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms	2007
Value of PET in the assessment of patients with neurofibromatosis type 1. AJR. American journal of roentgenology, 2007, Volume: 189, Issue:4 Topics: Adolescent; Adult; Aged; Carbon Isotopes; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging	2007
Varying degrees of FDG uptake in multiple benign neurofibromas on PET/CT. The British journal of radiology, 2007, Volume: 80, Issue:957 Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Mediastinal Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Tracheal Neoplasms	2007
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Biopsy, Needle; Child; Child, Preschool; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Probability; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, X-Ray Computed	2008
[Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1]. Annales de dermatologie et de venereologie, 2007, Volume: 134, Issue:10 Pt 1 Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma	2007
Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:12 Topics: Adolescent; Adult; Brain; Case-Control Studies; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Intellectual Disability; Language Development Disorders; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Seizures; Severity of Illness Index; Tomography, Emission-Computed	1994
Positron emission tomography in children with neurofibromatosis-1. Journal of child neurology, 1997, Volume: 12, Issue:8 Topics: Adolescent; Adult; Brain; Case-Control Studies; Cerebral Cortex; Child; Child, Preschool; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Neuropsychological Tests; Radiopharmaceuticals; Thalamus; Tomography, Emission-Computed	1997
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. Journal of neurology, neurosurgery, and psychiatry, 2000, Volume: 68, Issue:3 Topics: Adolescent; Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Tomography, Emission-Computed	2000
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer research, 2002, Mar-01, Volume: 62, Issue:5 Topics: Adolescent; Adult; Child; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1	2002